Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Feldmann

Showing results (21-30 of 99) with videos related to

Pageof 10
Sort By:
Hematology (Amsterdam, Netherlands)|May 19, 2023
Treatment of acute myeloid leukaemia in older patients - scope of intensive therapy? - A retrospective analysisKarin Mayer, Michael Serries, Corinna Hahn-Ast, et al.
International Journal of Gastrointestinal Cancer|September 11, 2007
Mitochondrial DNA mutations in pancreatic cancerKeyanoosh Kassauei, Nils Habbe, Michael E Mullendore, et al.
Journal of Nanobiotechnology|April 19, 2007
Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapySavita Bisht, Georg Feldmann, Sheetal Soni, et al.
International Journal of Molecular Sciences|June 19, 2024
Triple Blockade of Oncogenic RAS Signaling Using KRAS and MEK Inhibitors in Combination with Irradiation in Pancreatic CancerXuan Wang, Johanna Breuer, Stephan Garbe, et al.
World Journal of Gastroenterology|September 29, 2006
C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinomaThomas Gerhardt, Sabine Milz, Michael Schepke, et al.
Frontiers in Oncology|September 18, 2025
Chronification of metastatic leiomyosarcoma in 9 lines of therapy by precision oncology: a case report and review of the literatureChristian R Klein, Sebastian Koob, Verena Tischler, et al.
Cancers|February 27, 2026
Hypomethylating Agents and Venetoclax Based Triplets Targeting FLT3, IDH and KMT2A in Acute Myeloid Leukemia: Current Studies and Challenges of a Tailored ApproachElisa Santambrogio, Alessia Castellino, Ernesta Audisio, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 25, 2017
The impact of repeated cycles of radioligand therapy using [<sup>177</sup>Lu]Lu-PSMA-617 on renal function in patients with hormone refractory metastatic prostate cancerAnna Yordanova, Anja Becker, Elisabeth Eppard, et al.
Endocrine-Related Cancer|October 5, 2007
Snail and Sonic Hedgehog activation in neuroendocrine tumors of the ileumVolker Fendrich, Jens Waldmann, Farzad Esni, et al.
European Journal of Endocrinology|January 30, 2009
Unique expression pattern of the EMT markers Snail, Twist and E-cadherin in benign and malignant parathyroid neoplasiaVolker Fendrich, Jens Waldmann, Georg Feldmann, et al.
Pageof 10

Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
Hematology (Amsterdam, Netherlands)|May 19, 2023
Treatment of acute myeloid leukaemia in older patients - scope of intensive therapy? - A retrospective analysisKarin Mayer, Michael Serries, Corinna Hahn-Ast, et al.
International Journal of Gastrointestinal Cancer|September 11, 2007
Mitochondrial DNA mutations in pancreatic cancerKeyanoosh Kassauei, Nils Habbe, Michael E Mullendore, et al.
Journal of Nanobiotechnology|April 19, 2007
Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapySavita Bisht, Georg Feldmann, Sheetal Soni, et al.
International Journal of Molecular Sciences|June 19, 2024
Triple Blockade of Oncogenic RAS Signaling Using KRAS and MEK Inhibitors in Combination with Irradiation in Pancreatic CancerXuan Wang, Johanna Breuer, Stephan Garbe, et al.
World Journal of Gastroenterology|September 29, 2006
C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinomaThomas Gerhardt, Sabine Milz, Michael Schepke, et al.
Frontiers in Oncology|September 18, 2025
Chronification of metastatic leiomyosarcoma in 9 lines of therapy by precision oncology: a case report and review of the literatureChristian R Klein, Sebastian Koob, Verena Tischler, et al.
Cancers|February 27, 2026
Hypomethylating Agents and Venetoclax Based Triplets Targeting FLT3, IDH and KMT2A in Acute Myeloid Leukemia: Current Studies and Challenges of a Tailored ApproachElisa Santambrogio, Alessia Castellino, Ernesta Audisio, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 25, 2017
The impact of repeated cycles of radioligand therapy using [<sup>177</sup>Lu]Lu-PSMA-617 on renal function in patients with hormone refractory metastatic prostate cancerAnna Yordanova, Anja Becker, Elisabeth Eppard, et al.
Endocrine-Related Cancer|October 5, 2007
Snail and Sonic Hedgehog activation in neuroendocrine tumors of the ileumVolker Fendrich, Jens Waldmann, Farzad Esni, et al.
European Journal of Endocrinology|January 30, 2009
Unique expression pattern of the EMT markers Snail, Twist and E-cadherin in benign and malignant parathyroid neoplasiaVolker Fendrich, Jens Waldmann, Georg Feldmann, et al.
Pageof 10